The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Use of Liquid Biopsies for Patients With EGFR-Mutated NSCLC

Heather A. Wakelee, MD
Published Online: 8:44 PM, Mon June 13, 2016


Heather A. Wakelee, MD, associate professor of Medicine (Oncology), Stanford University Medical Center, discusses a study utilizing liquid biopsies in patients with non–small cell lung cancer who harbor EGFR mutations.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.